British Columbia's 'treatment-as-prevention strategy' helping to reduce HIV/AIDS cases, deaths

"New HIV cases and AIDS deaths are both going steadily down in British Columbia, according to data released last week," the New York Times reports. Julio Montaner, director of the British Columbia Centre for Excellence in HIV/AIDS, said, "We're particularly pleased to see that our treatment-as-prevention strategy has taken off big-time," the newspaper notes, adding that the strategy, which aggressively identifies and treats people with HIV, "lowers by 96 percent the chances that they will infect others." The New York Times writes, "Montaner said he is frustrated that rich countries will not donate enough money to roll out the strategy in poor countries with huge HIV epidemics" (McNeil, 1/2).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Affordability and supply remain critical to the success of long-lasting HIV drug